PEPTIDES

Growth marketing for peptide brands

Acquisition for peptide-therapy clinics and brands - a high-LTV, high-compliance category where a diversified funnel beats a fragile single-channel paid play.

Typical CAC ~$200–$400+ Compliance-first Setup in 5 days
The short answer Restructured a peptide clinic’s funnel to cut marketing from 60% toward 40% of revenue. We only work in health, so the playbook, creative, and compliance are purpose-built for peptides - not adapted from a generic DTC template.

Market context

The peptide therapeutics market is ~$140B in 2025, but the operator-relevant slice - compounded/telehealth "wellness" peptides (BPC-157, TB-500, sermorelin, CJC-1295/ipamorelin, PT-141) - is a consumer-awareness rocket, with Google interest in "peptides" up ~80% and "cost of peptide therapy" up ~300% YoY. The 2026 urgency is regulatory whiplash: HHS moved ~14 of 19 restricted peptides off the FDA’s Category 2 list and FDA pulled BPC-157/TB-500 out in April 2026 - but none are FDA-approved, none have a USP monograph, and a July 2026 review is pending, so brands operate in a gray zone where a licensed 503A/503B telehealth path is the only defensible model.

The peptides growth playbook

Marketing eats ~60% of revenue in many peptide clinics today, often concentrated on one paid channel that shares TRT’s ad-policy minefield.

Paid is mostly closed - build an organic + influencer moat

Meta and Google effectively prohibit direct peptide advertising (Meta bans HGH, DHEA, "unsafe substances"), and both tolerate only neutral educational content that does NOT link to a product/checkout. LegitScript logged a 308% YoY jump in problematic peptide ads with a matching enforcement surge. The durable channels are education-led SEO, practitioner/podcast influencers, email/SMS, affiliate, and community (Reddit, Discord) - treat paid social as top-of-funnel amplification only, never a conversion channel.

Win the SERP and the podcast, not the ad auction

The highest-ROI content is deep education mapped to intent keywords ("BPC-157 for tendon recovery," "sermorelin vs CJC-1295," "peptide therapy cost") plus credentialed-expert influencer content - physician/pharmacist/researcher voices convert and clear review, while consumer influencer claims are a compliance landmine. Angle around recovery, longevity, biohacking, and metabolic optimization with benefit framing, never disease-treatment claims.

Gate the funnel through telehealth

The compliant, scalable structure is education-led SEO → free or low-cost async provider consult → prescriber-gated 503A compounded script → recurring vial subscription. Gating behind a licensed practitioner is both the compliance shield and the trust unlock; "research use only" gray-market SKUs cap you at low-trust one-off buyers and maximal liability.

LTV lives in stacks, cycles, and refills

Peptides are inherently recurring - vials deplete, protocols run in cycles (e.g., 8-week BPC-157 courses), and biohackers stack complementary peptides. Build retention on auto-refill subscriptions, protocol/stack bundles, cycling reminders, and lab-retest touchpoints; the money is in the second-through-tenth order.

Compliance landmines

Watch for thisPeptides like BPC-157 face the same ad-policy restrictions as hormones, plus FDA compounding/regulatory scrutiny of the products themselves. Health claims are high-risk. GLP-1 on Meta after the 35-state-AG action: what changed →

Common mistakes in peptides

  • Trying to run Meta/Google paid ads on peptides at all - you’ll burn ad accounts, trip AI enforcement, and land on warning-letter lists.
  • Making disease-treatment claims ("heals injuries," "reverses aging") instead of compliant structure/function benefit language.
  • Selling "research use only / not for human consumption" vials while implying human dosing - the disclaimer doesn’t shield you and signals a gray-market brand.
  • Ignoring the moving FDA 503A/Category 2 list - building a catalog on a peptide that could face a compliance reversal overnight.
  • Skipping sourcing/quality proof (third-party COAs, 503A/503B pharmacy provenance) - trust gaps are the #1 conversion killer in a category buyers know is unregulated.

What good looks like

  • Organic/SEO + referral ≥ 70–80% of sessions (paid social is off the table)
  • Email/SMS-driven revenue ≥ 30–40% of total
  • Subscription/auto-refill attach ≥ 40–50% of orders
  • Blended CAC ~$80–150 via content/affiliate/influencer; 12-mo LTV 4–6× first order

Segments we work in

Recovery/healing (BPC-157, TB-500)GH secretagogues (sermorelin, CJC-1295/ipamorelin)Metabolic (AOD-9604)Sexual wellness (PT-141)Cosmetic/skin (GHK-Cu)Longevity (epitalon, thymosin alpha-1)

What we do for peptides brands

Compliant paid media

Meta, Google & TikTok, structured for this vertical’s auction.

Learn more →

In-house creative

20+ compliant variants a month, built around winning angles.

Learn more →

CRO & funnels

Quiz funnels and landers tuned to LTV and payback.

Learn more →

Peptides marketing FAQ

Published CAC is opaque, but telehealth peptide acquisition runs 20–40% below in-clinic, landing roughly $200–$400+ fully-loaded with wide variance. With $4,000–$6,000 in annual revenue per patient, the LTV easily supports that CAC.

It’s restricted - peptides face the same ad-policy landmines as hormones, plus FDA compounding scrutiny. The durable approach is a diversified funnel (SEO, content, referral, consultation) rather than betting the clinic on one restricted paid channel.

Both platforms classify peptides under prohibited/unsafe substances and unapproved health-product policies - Meta explicitly bans HGH, DHEA, and "unsafe supplements," and neither allows ads linking to a peptide product or checkout. With a documented 308% YoY spike in problematic peptide ads and AI-driven enforcement, attempts get disapproved fast and put your ad account and domain at risk.

Route everything through a licensed prescriber and a 503A/503B compounding pharmacy, market with structure/function benefit language (never cure/treat claims), and lean on education-led SEO, credentialed-expert (MD/PharmD) influencer and podcast content, owned email/SMS, and performance-based affiliates. Publish third-party COAs and pharmacy provenance for trust, and wall off any "research use only" catalog from human-use messaging.

Ready to lower CAC on your peptides brand?

A 30-minute call with a senior strategist. Free account audit included. No pitch deck - a written plan you can keep, whether you work with us or not.

Book a free strategy call
30 minutes Free account audit Written plan either way
Book a free strategy call